An improved patient-derived xenograft humanized mouse model for evaluation of lung cancer immune responses
IM Meraz, M Majidi, F Meng, RP Shao, MJ Ha… - Cancer immunology …, 2019 - AACR
Human tumor xenograft models do not replicate the human immune system and tumor
microenvironment. We developed an improved humanized mouse model, derived from fresh cord …
microenvironment. We developed an improved humanized mouse model, derived from fresh cord …
Reduced cationic nanoparticle cytotoxicity based on serum masking of surface potential
KI McConnell, S Shamsudeen, IM Meraz… - Journal of …, 2016 - ingentaconnect.com
Functionalization of nanoparticles with cationic moieties, such as polyethyleneimine (PEI),
enhances binding to the cell membrane; however, it also disrupts the integrity of the cell's …
enhances binding to the cell membrane; however, it also disrupts the integrity of the cell's …
Adjuvant cationic liposomes presenting MPL and IL-12 induce cell death, suppress tumor growth, and alter the cellular phenotype of tumors in a murine model of …
IM Meraz, DJ Savage, V Segura-Ibarra, J Li… - Molecular …, 2014 - ACS Publications
Dendritic cells (DC) process and present antigens to T lymphocytes, inducing potent immune
responses when encountered in association with activating signals, such as pathogen-…
responses when encountered in association with activating signals, such as pathogen-…
TUSC2 Immunogene Therapy Synergizes with Anti–PD-1 through Enhanced Proliferation and Infiltration of Natural Killer Cells in Syngeneic Kras-Mutant Mouse Lung …
Expression of the multikinase inhibitor encoded by the tumor suppressor gene TUSC2 (also
known as FUS1) is lost or decreased in non–small cell lung carcinoma (NSCLC). TUSC2 …
known as FUS1) is lost or decreased in non–small cell lung carcinoma (NSCLC). TUSC2 …
Activation of the inflammasome and enhanced migration of microparticle-stimulated dendritic cells to the draining lymph node
IM Meraz, B Melendez, J Gu, STC Wong… - Molecular …, 2012 - ACS Publications
Porous silicon microparticles presenting pathogen-associated molecular patterns mimic
pathogens, enhancing internalization of the microparticles and activation of antigen presenting …
pathogens, enhancing internalization of the microparticles and activation of antigen presenting …
[HTML][HTML] TUSC2 immunogene enhances efficacy of chemo-immuno combination on KRAS/LKB1 mutant NSCLC in humanized mouse model
IM Meraz, M Majidi, RP Shao, F Meng, MJ Ha… - Communications …, 2022 - nature.com
KRAS/LKB1 (STK11) NSCLC metastatic tumors are intrinsically resistant to anti-PD-1 or PD-L1
immunotherapy. In this study, we use a humanized mouse model to show that while …
immunotherapy. In this study, we use a humanized mouse model to show that while …
Enterotoxigenic Escherichia coli and Diffusely Adherent E coli as Likely Causes of a Proportion of Pathogen‐Negative Travelers' Diarrhea—A PCR‐Based Study
IM Meraz, ZD Jiang, CD Ericsson… - Journal of travel …, 2008 - academic.oup.com
Background Enteropathogens cannot be identified in 40% to 50% of subjects with travelers’
diarrhea (TD). Methods We used polymerase chain reaction (PCR) methods to look for the …
diarrhea (TD). Methods We used polymerase chain reaction (PCR) methods to look for the …
[HTML][HTML] Multivalent presentation of MPL by porous silicon microparticles favors T helper 1 polarization enhancing the anti-tumor efficacy of doxorubicin …
IM Meraz, CH Hearnden, X Liu, M Yang, L Williams… - PloS one, 2014 - journals.plos.org
Porous silicon (pSi) microparticles, in diverse sizes and shapes, can be functionalized to
present pathogen-associated molecular patterns that activate dendritic cells. Intraperitoneal …
present pathogen-associated molecular patterns that activate dendritic cells. Intraperitoneal …
A focal adhesion kinase-YAP signaling axis drives drug tolerant persister cells and residual disease in lung cancer
…, C Fernández-Méndez, L Čech, J Yu, IM Meraz… - BioRxiv, 2021 - biorxiv.org
Targeted therapy is effective in many tumor types including lung cancer, the leading cause
of cancer mortality. Paradigm defining examples are targeted therapies directed against non-…
of cancer mortality. Paradigm defining examples are targeted therapies directed against non-…
Serine proteases enhance immunogenic antigen presentation on lung cancer cells
Immunotherapies targeting immune checkpoints have proven efficacious in reducing the
burden of lung cancer in patients; however, the antigenic targets of these reinvigorated T cells …
burden of lung cancer in patients; however, the antigenic targets of these reinvigorated T cells …